KR950702828A - 불필요한 세포 또는 조직의 사멸 또는 성장억제방법(method for destroying or inhibiting growth of unwanted cells or tissues) - Google Patents
불필요한 세포 또는 조직의 사멸 또는 성장억제방법(method for destroying or inhibiting growth of unwanted cells or tissues) Download PDFInfo
- Publication number
- KR950702828A KR950702828A KR1019950700623A KR19950700623A KR950702828A KR 950702828 A KR950702828 A KR 950702828A KR 1019950700623 A KR1019950700623 A KR 1019950700623A KR 19950700623 A KR19950700623 A KR 19950700623A KR 950702828 A KR950702828 A KR 950702828A
- Authority
- KR
- South Korea
- Prior art keywords
- bpd
- tissues
- alkyl
- cells
- malignant cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract 21
- 230000002401 inhibitory effect Effects 0.000 title claims 2
- -1 benzoporphyrin derivative compound Chemical class 0.000 claims abstract 5
- 230000005865 ionizing radiation Effects 0.000 claims abstract 5
- 230000005855 radiation Effects 0.000 claims abstract 5
- 150000001875 compounds Chemical class 0.000 claims abstract 4
- 230000001678 irradiating effect Effects 0.000 claims abstract 4
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 230000003211 malignant effect Effects 0.000 claims 8
- 239000003623 enhancer Substances 0.000 claims 6
- 210000001124 body fluid Anatomy 0.000 claims 5
- 239000010839 body fluid Substances 0.000 claims 5
- 125000003107 substituted aryl group Chemical group 0.000 claims 4
- 125000005916 2-methylpentyl group Chemical group 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000001475 halogen functional group Chemical group 0.000 claims 3
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 230000006378 damage Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93016592A | 1992-08-17 | 1992-08-17 | |
| US70/930,165 | 1992-08-17 | ||
| PCT/CA1993/000328 WO1994004147A1 (en) | 1992-08-17 | 1993-08-17 | Method for destroying or inhibiting growth of unwanted cells or tissues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR950702828A true KR950702828A (ko) | 1995-08-23 |
Family
ID=51400872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019950700623A Withdrawn KR950702828A (ko) | 1992-08-17 | 1993-08-17 | 불필요한 세포 또는 조직의 사멸 또는 성장억제방법(method for destroying or inhibiting growth of unwanted cells or tissues) |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR950702828A (enrdf_load_stackoverflow) |
| TW (1) | TW241206B (enrdf_load_stackoverflow) |
-
1993
- 1993-08-17 KR KR1019950700623A patent/KR950702828A/ko not_active Withdrawn
- 1993-10-05 TW TW082108215A patent/TW241206B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| TW241206B (enrdf_load_stackoverflow) | 1995-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU90718I2 (fr) | Visudyne-verteporfin et ses d-riv-s pharmaceutiquement acceptables | |
| DE69523350D1 (de) | Behandlung von hyperproliferativen Gefässerkrankungen | |
| NO951066D0 (no) | Transkutan in vivo aktivering av fotosensitive midler i blod | |
| EP0637976A1 (en) | LASER TREATMENT. | |
| NO974275D0 (no) | Fremgangsmåte for behandling av tumorer | |
| CA2182010A1 (en) | Photochemical ablation of gastro-intestinal tissue | |
| ES2153851T3 (es) | Tratamiento de la atrofia de la piel y de la vagina. | |
| ATE209908T1 (de) | RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN | |
| DE69526956D1 (de) | Proteinkinase c-inhibitoren zur behandlung von neurologischen erkrankungen | |
| ES2125276T3 (es) | Tratamiento de acne o de pseudofolliculitis barbae | |
| DE69320646D1 (de) | Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'-halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff | |
| DE69631478D1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| ATE122232T1 (de) | Melatoninderivate und kombinationen mit antiestrogenen zur behandlung von brustkarzinoma. | |
| EA200200738A1 (ru) | Способ и состав для лечения невосприимчивости организма к гипотензивным средствам и связанных с ней состояний | |
| Dillon et al. | In vitro and in vivo protection against phototoxic side effects of photodynamic therapy by radioprotective agentswr–2721 andwr–77913 | |
| PT768886E (pt) | Efeitos de revestimento endotelial e tratamento de desordens vasospasticas | |
| ATE180669T1 (de) | Verwendung von pregnanderivaten zur behandlung von tumoren | |
| KR950702828A (ko) | 불필요한 세포 또는 조직의 사멸 또는 성장억제방법(method for destroying or inhibiting growth of unwanted cells or tissues) | |
| ATE90563T1 (de) | Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie. | |
| DE69419954D1 (de) | Arzneimittel zur Behandlung von Hauterkrankungen | |
| BR9603454A (pt) | Composição e método para tratamento de câncer de próstata | |
| ATE82850T1 (de) | Verwendung von 2-pyrimidinyl-1-piperazinderivaten. | |
| ATE148626T1 (de) | Katecholderivate, deren physiologisch unbedenkliche salze, ester und deren verwendung bei der behandlung von durch lipidperoxidation verursachten gewebeschäden | |
| EA199900363A1 (ru) | Новые производные пентаэритрита, их получение и применение, а также промежуточные продукты для их синтеза | |
| NO910033L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19950217 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |